© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

More articles/Ad

More articles/Ad

More articles

  • Indian equity capital market volumes may be down on last year, but there is no dearth of IPOs. The animal spirits are clearly present in the country as confidence grows in new companies, which are coming in greater numbers to tap both foreign interest and a resurgent domestic investor base. Jonathan Breen and John Loh report.
  • The Securities Commission Malaysia (SC) has released a consultation paper seeking public feedback to improve its guidelines on real estate investment trusts (Reits), it said on Thursday.
  • The India government has given the nod for a 15% stake sale in state-owned National Buildings Construction Corp to raise a potential Rp17bn ($253.9m).
  • GenSight Biologics, a niche French biotechnology firm focused on treating degenerative retinal and nervous system disorders, has completed its all-primary IPO on Euronext Paris, raising €46m to help bring its flagship drug GS010 to market in Europe and the US.
  • UniCredit has dominated the headlines again this week, but this time for a better reason. Italy’s largest bank has also been its biggest loser of shareholder value, its shares falling 75% since last summer, as investors have lost trust in the sector.
  • Shandong International Trust Corp, which is planning a $300m Hong Kong listing, is set to ask for approval for the deal in September, according to a source familiar with matter.